iBio, Inc

(NYSE MKT:IBIO)

Latest On iBio, Inc (IBIO):

Date/Time Type Description Signal Details
2023-04-05 23:34 ESTNewsiBio finds new panel of CD3 T-cell binding antibodiesN/A
2023-02-17 04:10 ESTNewsiBio shares more than double in value after hours on new immuno-oncology target programN/A
2022-12-07 14:33 ESTNewsiBio shares slide on pricing $3.5M securities offeringN/A
2022-12-06 20:47 ESTNewsiBio intends to offer and sell shares, purchase warrants in underwritten public offeringN/A
2022-12-05 09:44 ESTNewsiBio's CEO Thomas F. Isett departsN/A
2022-10-07 17:25 ESTNewsiBio cut to Neutral at Cantor citing ongoing transitionN/A
2022-09-28 20:09 ESTNewsiBio is right to move away from COVID-19 vaccine development - CantorN/A
2022-09-28 04:29 ESTNewsiBio down 28% after reporting FY 2022 resultsN/A
2022-09-28 04:29 ESTNewsiBio, Inc. (IBIO) Q4 2022 Results - Earnings Call TranscriptN/A
2022-09-22 02:32 ESTNewsiBio acquires AI-drug discovery company RubrYc Therapeutics, shares rise ~9%N/A
2022-08-17 02:45 ESTNewsiBio provides update on development of COVID-19 vaccine candidateN/A
2022-07-06 23:38 ESTNewsiBio shareholders approve 1-for-25 reverse stock splitN/A
2022-06-06 22:02 ESTNewsClover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletionsN/A
2022-06-06 22:02 ESTNewsInovio Pharma, Bionano Genomics among health care stocks to join Russell Microcap Index; Tonix Pharma, iBio to leaveN/A
2022-05-13 17:19 ESTNewsiBio, Inc. (IBIO) CEO Tom Isett on Q3 2022 Results - Earnings Call TranscriptN/A
2022-05-13 17:18 ESTNewsiBio quarterly net loss widens 61% even as revenue shows strong gainN/A
2022-05-13 17:17 ESTNewsiBio, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-12 18:44 ESTNewsiBio GAAP EPS of -$0.06 in-line, revenue of $1.94M beats by $1.74MN/A
2022-05-12 00:35 ESTNewsiBio FQ3 2022 Earnings PreviewN/A
2022-05-09 11:38 ESTNewsiBio cancer drug candidate IBIO-101 shows efficacy in preclinical trialN/A
2022-03-26 02:04 ESTNewsiBio extends recent gains; Can the rally continue?N/A
2022-02-15 05:38 ESTNewsiBio GAAP EPS of -$0.05 misses by $0.01, revenue of $0.17M misses by $0.08MN/A
2022-02-15 05:37 ESTNewsiBio, Inc. (IBIO) CEO Tom Isett on Q2 2022 Results - Earnings Call TranscriptN/A
2022-02-14 09:29 ESTNewsiBio Q2 2022 Earnings PreviewN/A
2022-01-26 22:59 ESTNewsiBio provides update on COVID-19 vaccine program IBIO-202N/A
2021-11-30 06:03 ESTNewsiBio rises 16% as it says COVID vaccine candidate may be effective against OmicronN/A
2021-11-16 02:35 ESTNewsiBio misses on revenueN/A
2021-11-16 02:35 ESTNewsiBio, Inc. (IBIO) CEO Thomas Isett on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-15 06:51 ESTNewsiBio FQ1 2022 Earnings PreviewN/A
2021-11-04 10:47 ESTNewsiBio rises 18% on acquiring manufacturing facility, takes ownership of CDMO entityN/A
2021-10-13 02:24 ESTNewsWarning: IBIO is at high risk of performing badlyN/A
2021-10-06 09:44 ESTNewsIBIO is at high risk of performing badlyN/A
2021-09-27 19:15 ESTNewsiBio misses on revenue; sees sequential decline in revenue during 1H22 vs. 2H21N/A
2021-09-27 19:15 ESTNewsiBio, Inc. (IBIO) CEO Thomas Isett on Q4 Fiscal 2021 Results - Earnings Call TranscriptN/A
2021-08-26 14:35 ESTNewsiBio adds William Clark to board of directorsN/A
2021-07-21 12:08 ESTNewsiBio adds veteran biopharmaceutical executive to board of directorsN/A
2021-07-21 11:47 ESTNewsiBio says successful in preclinical studies for subunit COVID-19 vaccine candidateN/A
2021-05-07 09:54 ESTNewsiBio shares surge on COVID-19 study updateN/A
2021-05-07 09:54 ESTNewsChemoCentryx downgraded on narrow Adcom backing, Tilray jumps on double upgrade; in today’s analyst actionN/A
2021-05-04 21:10 ESTNewsiBio shares surge after resolving Fraunhofer USA lawsuitN/A
2021-04-26 22:03 ESTNewsiBio: New Strategy And Management Changes May Bring A Much-Needed ResetN/A
2021-02-17 23:51 ESTFinancialsCompany financials have been released.Neutral
2021-02-17 04:45 ESTNewsiBio beats on revenueN/A
2021-02-17 04:45 ESTNewsDespite narrower fiscal Q2 2021 loss, iBio expenses grow; shares fall after hoursN/A
2021-02-17 04:45 ESTNewsiBio, Inc. (IBIO) CEO Tom Isett on Q2 2021 Results - Earnings Call TranscriptN/A
2021-01-22 16:03 ESTNewsiBio surges after Cantor Fitzgerald initiates coverage with overweight ratingN/A
2021-01-22 03:51 ESTAnalyst RatingThe Analyst Target Price has increased from $2 to $2.5.Buy
2021-01-03 20:31 ESTNewsCould a COVID vaccine passport be issued in the U.S.?N/A
2021-01-01 08:41 ESTNewsIsrael leads world in COVID vaccinations per capitaN/A
2020-12-28 09:59 ESTNewsiBio appoints new Chief Scientific OfficerN/A

About iBio, Inc (IBIO):

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and related conditions. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with AzarGen Biotechnologies (Pty) Ltd (AzarGen) for the contract development and manufacturing services for AzarGen's development of a rituximab biosimilar/biobetter for the South African market; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; collaboration with EdgePoint AI, a division of Mateon Therapeutics, Inc.; and collaboration agreement with CC-Pharming Ltd. iBio, Inc. is headquartered in New York, New York.

IBIO Quotes by TradingView

See Advanced Chart

General

  • Name iBio, Inc
  • Symbol IBIO
  • Type Common Stock
  • Exchange NYSE MKT
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Last Split Factor1:10
  • Last Split Date2018-06-11
  • Fiscal Year EndJune
  • IPO Date2008-08-19
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ibioinc.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 106.55
  • Price/Book (Most Recent Quarter) 3.68
  • Enterprise Value Revenue 137.46
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.19
  • Next Year EPS Estimate -$0.21
  • Next Quarter EPS Estimate -$0.05
  • Operating Margin -921%
  • Return on Assets -15%
  • Return on Equity -45%
  • Revenue 2.33 million
  • Earnings Per Share -$0.94
  • Revenue Per Share $0.02
  • Gross Profit 1.64 million
  • Quarterly Earnings Growth 124.5%
View More

Highlights

  • Market Capitalization 366.14 million
  • EBITDA -13860000
  • Analyst Target Price $2.5
  • Book Value Per Share $0.51
View More

Share Statistics

  • Shares Outstanding 216.01 million
  • Shares Float 215.41 million
  • % Held by Insiders 91%
  • % Held by Institutions 8.1%
  • Shares Short 10.23 million
  • Shares Short Prior Month 12.96 million
  • Short Ratio 0.5
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta -6.14
  • 52 Week High $7.45
  • 52 Week Low $0.76
  • 50 Day Moving Average 1.92
  • 200 Day Moving Average 1.75
View More

Dividends

  • Dividend Date 2018-06-11
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

iBio, Inc (IBIO) Dividend Calendar:

IBIO's last dividend payment was made to shareholders on June 11, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

iBio, Inc (IBIO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-16$N/A-$0.04-$0.04-14.29%
2020-09-302020-11-16$N/A-$0.05-$0.0837.5%
2020-03-312020-05-15$96000-$0.06
2019-12-312020-02-14$314000-$0.69
2019-09-302019-11-14$N/A-$0.21
2019-06-302019-08-26$795000-$0.23
2019-03-312019-05-10$527000-$0.22
2018-12-312019-02-13$651000-$0.24
2018-09-302018-11-13$45000-$0.25
2018-06-302018-09-18$91000-$0.34
2018-03-312018-05-11$78000-$0.35
2017-12-312018-02-15$155000-$0.41
2017-09-302017-11-09$131000-$0.42
2017-06-302017-09-15$152000-$0.49
2017-03-312017-05-15$37000-$0.44
2016-12-312017-02-21$79000-$0.36
2016-09-302016-10-13$147000-$0.34
2016-06-302016-08-31$279000-$0.30
2016-03-312016-06-01$384000-$0.37
2015-12-312016-03-02$140000-$0.29
2015-09-302015-12-02$166000-$0.23
2015-06-302015-09-02$324000-$0.20
2015-03-312015-06-03$358000-$0.23
2014-12-312015-02-25$377000-$0.23
2014-09-302014-12-03$824000-$0.21
2014-06-302014-09-03$213000-$0.17
2014-03-312014-05-28$9000-$0.19
2013-12-312014-02-26$10000-$0.25
2013-09-302013-11-27$15000$0.06
2013-03-312013-05-29$7000-$0.37
2012-12-312013-02-27$3000-$0.22
2012-09-302012-10-12$402000-$0.20-$0.9077.78%
2012-06-302012-08-29$354000-$0.34
2012-03-312012-05-15$386000-$0.70-$0.65-7.69%
2011-12-312012-02-29$239000-$0.49
2011-09-302011-11-14$332000$0.10-$0.70114.29%
2011-06-302011-09-29$353000-$0.40-$0.7042.86%
2011-03-312011-05-18$180000-$0.90-$0.40-125%
2010-12-312011-02-14$3000-$1.50-$0.40-275%
2010-09-302010-10-13$7000-$0.90-$0.30-200%
2010-06-302010-09-01$10000-$0.95
2010-03-312010-05-19$4000-$0.60-$0.20-200%
2009-12-312010-02-16$4000-$0.10-$1.0090%
2009-09-302009-09-30$9000-$0.23
2009-06-302009-06-30$138000-$0.23
2009-03-312009-03-31$326000-$0.14
2008-12-312008-12-31$380000-$0.24
2008-09-302008-09-30$333000-$0.50

iBio, Inc (IBIO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

iBio, Inc (IBIO) Chart:

iBio, Inc (IBIO) News:

Below you will find a list of latest news for iBio, Inc (IBIO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

iBio, Inc (IBIO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-06-2110.04CALL6 00TRUE00
2024-06-2120CALL0 00FALSE00
2024-06-2130.05CALL0 300FALSE00
2024-06-2110PUT0 00FALSE00
2024-06-2121.75PUT0 20TRUE00
2024-06-2130PUT0 00TRUE00

Latest IBIO Trades:

Date Shares Price
Jun 13, 2022 7:55 PM EST100$0.2675
Jun 13, 2022 7:55 PM EST100$0.2675
Jun 13, 2022 7:55 PM EST100$0.2676
Jun 13, 2022 7:58 PM EST200$0.2681
Jun 13, 2022 7:58 PM EST100$0.2681

iBio, Inc (IBIO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1420720/000110465920074240/0001104659-20-074240-index.htm
2018-05-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1420720/000000000018014655/0000000000-18-014655-index.htm
2019-09-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1420720/000000000019013230/0000000000-19-013230-index.htm
2020-03-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1420720/000000000020002159/0000000000-20-002159-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465919055566/0001104659-19-055566-index.htm
2019-10-24S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1420720/000110465919055938/0001104659-19-055938-index.htm
2019-10-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1420720/000110465919056071/0001104659-19-056071-index.htm
2019-10-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1420720/000110465919056079/0001104659-19-056079-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465919056599/0001104659-19-056599-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465919056697/0001104659-19-056697-index.htm
2019-10-28424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1420720/000110465919056978/0001104659-19-056978-index.htm
2019-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465919057346/0001104659-19-057346-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1420720/000110465919064178/0001104659-19-064178-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465919072630/0001104659-19-072630-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920002677/0001104659-20-002677-index.htm
2020-01-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1420720/000110465920002678/0001104659-20-002678-index.htm
2020-01-13PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920003148/0001104659-20-003148-index.htm
2020-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920004733/0001104659-20-004733-index.htm
2020-01-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920006289/0001104659-20-006289-index.htm
2020-02-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1420720/000110465920012017/0001104659-20-012017-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920012018/0001104659-20-012018-index.htm
2020-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1420720/000110465920020473/0001104659-20-020473-index.htm
2020-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920023642/0001104659-20-023642-index.htm
2020-02-258-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920024803/0001104659-20-024803-index.htm
2020-02-28S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1420720/000110465920026461/0001104659-20-026461-index.htm
2020-03-02DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1420720/000110465920027960/0001104659-20-027960-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920030822/0001104659-20-030822-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920032700/0001104659-20-032700-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920032748/0001104659-20-032748-index.htm
2020-03-13S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1420720/000110465920033166/0001104659-20-033166-index.htm
2020-03-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1420720/000110465920033174/0001104659-20-033174-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920035321/0001104659-20-035321-index.htm
2020-03-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1420720/000110465920035596/0001104659-20-035596-index.htm
2020-03-198-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920035835/0001104659-20-035835-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920036299/0001104659-20-036299-index.htm
2020-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1420720/000110465920036304/0001104659-20-036304-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920040348/0001104659-20-040348-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920045157/0001104659-20-045157-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920051125/0001104659-20-051125-index.htm
2020-05-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1420720/000110465920061206/0001104659-20-061206-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920061211/0001104659-20-061211-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1420720/000110465920062716/0001104659-20-062716-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920073831/0001104659-20-073831-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920073945/0001104659-20-073945-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920074230/0001104659-20-074230-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1420720/000110465920074240/0001104659-20-074240-index.htm
2020-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920082413/0001104659-20-082413-index.htm
2020-07-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1420720/000110465920087529/0001104659-20-087529-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920087532/0001104659-20-087532-index.htm
2020-07-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1420720/000110465920087542/0001104659-20-087542-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920094646/0001104659-20-094646-index.htm
2020-09-28NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1420720/000110465920109056/0001104659-20-109056-index.htm
2020-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920111404/0001104659-20-111404-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920111985/0001104659-20-111985-index.htm
2020-10-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920111995/0001104659-20-111995-index.htm
2020-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920113931/0001104659-20-113931-index.htm
2020-10-138-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920114175/0001104659-20-114175-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920114529/0001104659-20-114529-index.htm
2020-10-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1420720/000110465920114567/0001104659-20-114567-index.htm
2020-10-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920115441/0001104659-20-115441-index.htm
2020-10-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920115447/0001104659-20-115447-index.htm
2020-10-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920115450/0001104659-20-115450-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920115456/0001104659-20-115456-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920115457/0001104659-20-115457-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920115459/0001104659-20-115459-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920115635/0001104659-20-115635-index.htm
2020-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920117141/0001104659-20-117141-index.htm
2020-10-23PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920117774/0001104659-20-117774-index.htm
2020-10-2710-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1420720/000110465920118585/0001104659-20-118585-index.htm
2020-10-284/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920118870/0001104659-20-118870-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000110465920120730/0001104659-20-120730-index.htm
2020-11-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1420720/000110465920121027/0001104659-20-121027-index.htm
2020-11-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1420720/000110465920122488/0001104659-20-122488-index.htm
2018-01-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418001109/0001144204-18-001109-index.htm
2018-01-09424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1420720/000114420418001486/0001144204-18-001486-index.htm
2018-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1420720/000114420418009023/0001144204-18-009023-index.htm
2018-03-21PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1420720/000114420418016205/0001144204-18-016205-index.htm
2018-04-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1420720/000114420418018934/0001144204-18-018934-index.htm
2018-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418022361/0001144204-18-022361-index.htm
2018-05-02S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1420720/000114420418024851/0001144204-18-024851-index.htm
2018-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1420720/000114420418027689/0001144204-18-027689-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418031975/0001144204-18-031975-index.htm
2018-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418033557/0001144204-18-033557-index.htm
2018-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418033574/0001144204-18-033574-index.htm
2018-06-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1420720/000114420418033666/0001144204-18-033666-index.htm
2018-06-13FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1420720/000114420418034051/0001144204-18-034051-index.htm
2018-06-21S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1420720/000114420418035025/0001144204-18-035025-index.htm
2018-06-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1420720/000114420418035027/0001144204-18-035027-index.htm
2018-06-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1420720/000114420418035028/0001144204-18-035028-index.htm
2018-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418035244/0001144204-18-035244-index.htm
2018-06-22424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1420720/000114420418035385/0001144204-18-035385-index.htm
2018-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418035914/0001144204-18-035914-index.htm
2018-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418038205/0001144204-18-038205-index.htm
2018-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418045937/0001144204-18-045937-index.htm
2018-09-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1420720/000114420418049866/0001144204-18-049866-index.htm
2018-11-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1420720/000114420418058814/0001144204-18-058814-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1420720/000114420418059349/0001144204-18-059349-index.htm
2018-11-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1420720/000114420418060776/0001144204-18-060776-index.htm
2018-12-17SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1420720/000114420418064899/0001144204-18-064899-index.htm
2018-12-17SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1420720/000114420418064901/0001144204-18-064901-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418065716/0001144204-18-065716-index.htm
2018-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420418066239/0001144204-18-066239-index.htm
2019-01-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1420720/000114420419001758/0001144204-19-001758-index.htm
2019-01-22SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1420720/000114420419002276/0001144204-19-002276-index.htm
2019-02-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1420720/000114420419007128/0001144204-19-007128-index.htm
2019-03-13SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1420720/000114420419013708/0001144204-19-013708-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420419017417/0001144204-19-017417-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1420720/000114420419025332/0001144204-19-025332-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420419029226/0001144204-19-029226-index.htm
2019-08-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1420720/000114420419041659/0001144204-19-041659-index.htm
2019-08-28S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1420720/000114420419042112/0001144204-19-042112-index.htm
2019-09-17FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1420720/000114420419044768/0001144204-19-044768-index.htm
2019-10-11FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1420720/000114420419047989/0001144204-19-047989-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1420720/000114420419048002/0001144204-19-048002-index.htm
2019-10-15S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1420720/000114420419048154/0001144204-19-048154-index.htm
2018-06-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840818000011/0001408408-18-000011-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000140840818000014/0001408408-18-000014-index.htm
2018-07-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840818000017/0001408408-18-000017-index.htm
2018-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000140840818000018/0001408408-18-000018-index.htm
2019-01-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840819000006/0001408408-19-000006-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000140840819000007/0001408408-19-000007-index.htm
2019-03-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840819000010/0001408408-19-000010-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000140840819000014/0001408408-19-000014-index.htm
2020-01-314/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000003/0001408408-20-000003-index.htm
2020-01-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000004/0001408408-20-000004-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000015/0001408408-20-000015-index.htm
2020-03-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000018/0001408408-20-000018-index.htm
2020-08-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000033/0001408408-20-000033-index.htm
2020-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000039/0001408408-20-000039-index.htm
2020-08-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000042/0001408408-20-000042-index.htm
2020-08-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000044/0001408408-20-000044-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000047/0001408408-20-000047-index.htm
2020-08-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1420720/000140840820000050/0001408408-20-000050-index.htm
2019-04-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000426/0001638599-19-000426-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000500/0001638599-19-000500-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000502/0001638599-19-000502-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000504/0001638599-19-000504-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000506/0001638599-19-000506-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000507/0001638599-19-000507-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000508/0001638599-19-000508-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000509/0001638599-19-000509-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000510/0001638599-19-000510-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000511/0001638599-19-000511-index.htm
2019-05-314/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000574/0001638599-19-000574-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000575/0001638599-19-000575-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000576/0001638599-19-000576-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000579/0001638599-19-000579-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000580/0001638599-19-000580-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000581/0001638599-19-000581-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000582/0001638599-19-000582-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000583/0001638599-19-000583-index.htm
2019-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000718/0001638599-19-000718-index.htm
2019-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000719/0001638599-19-000719-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859919000935/0001638599-19-000935-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859920000306/0001638599-20-000306-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859920000336/0001638599-20-000336-index.htm
2020-04-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859920000401/0001638599-20-000401-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859920000520/0001638599-20-000520-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859920000552/0001638599-20-000552-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1420720/000163859920000582/0001638599-20-000582-index.htm
2018-06-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1420720/999999999518001568/9999999995-18-001568-index.htm
2019-10-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1420720/999999999519002378/9999999995-19-002378-index.htm
2020-03-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1420720/999999999520000593/9999999995-20-000593-index.htm

iBio, Inc (IBIO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of iBio, Inc (IBIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 91%
Institutional Ownership: 810%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-27James P. MullaneyChief Financial OfficerBuy11,250.000.9310,462.500.00https://www.sec.gov/Archives/edgar/data/1420720/000163859920000520/0001638599-20-000520-index.htm
2020-05-27James P. MullaneyChief Financial OfficerSell11,250.001.6118,112.500.00https://www.sec.gov/Archives/edgar/data/1420720/000163859920000520/0001638599-20-000520-index.htm
2020-06-04ROBERT L ERWINPresidentBuy28,268.000.9326,289.24108,108.00https://www.sec.gov/Archives/edgar/data/1420720/000163859920000582/0001638599-20-000582-index.htm
2020-06-04ROBERT L ERWINPresidentSell28,268.001.7148,338.28108,108.00https://www.sec.gov/Archives/edgar/data/1420720/000163859920000582/0001638599-20-000582-index.htm
2020-06-02ROBERT L ERWINPresidentBuy96,124.000.9389,395.32136,376.00https://www.sec.gov/Archives/edgar/data/1420720/000163859920000552/0001638599-20-000552-index.htm
2020-06-02ROBERT L ERWINPresidentSell96,124.001.62155,720.88136,376.00https://www.sec.gov/Archives/edgar/data/1420720/000163859920000552/0001638599-20-000552-index.htm
2020-08-10Capital LTD Eastern10% Share HolderSell7,264,864.003.9128,429,592.2924,494,129.00https://www.sec.gov/Archives/edgar/data/1420720/000140840820000047/0001408408-20-000047-index.htm
2020-08-07Capital LTD Eastern10% Share HolderSell1,355,604.003.835,185,591.9831,758,993.00https://www.sec.gov/Archives/edgar/data/1420720/000140840820000047/0001408408-20-000047-index.htm
2020-08-06Capital LTD Eastern10% Share HolderSell2,768,137.004.1811,570,535.8533,114,597.00https://www.sec.gov/Archives/edgar/data/1420720/000140840820000039/0001408408-20-000039-index.htm
2020-08-05Capital LTD Eastern10% Share HolderSell900,000.004.464,013,550.0035,882,734.00https://www.sec.gov/Archives/edgar/data/1420720/000140840820000039/0001408408-20-000039-index.htm
2020-08-04Capital LTD Eastern10% Share HolderSell600,000.004.392,636,640.0036,782,734.00https://www.sec.gov/Archives/edgar/data/1420720/000140840820000039/0001408408-20-000039-index.htm
2018-06-26Capital LTD Eastern10% Share HolderBuy1,683,334.000.901,515,000.606,257,734.00https://www.sec.gov/Archives/edgar/data/1420720/000140840818000014/0001408408-18-000014-index.htm
2018-07-12Capital LTD Eastern10% Share HolderBuy2,200,000.000.901,980,000.008,457,734.00https://www.sec.gov/Archives/edgar/data/1420720/000140840818000018/0001408408-18-000018-index.htm
2020-08-11Capital LTD Eastern10% Share HolderSell15,864,436.002.9246,330,498.898,629,693.00https://www.sec.gov/Archives/edgar/data/1420720/000140840820000047/0001408408-20-000047-index.htm